Variant report
Variant | nsv968547 |
---|---|
Chromosome Location | chr8:63513664-63516241 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147731589 | chr8:63515021-63515022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530293273 | chr8:63515078-63515079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373781063 | chr8:63515113-63515114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548783394 | chr8:63515168-63515169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76234652 | chr8:63515173-63515174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537583878 | chr8:63515174-63515175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559083029 | chr8:63515175-63515176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551076391 | chr8:63515243-63515244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570904062 | chr8:63515259-63515260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535019122 | chr8:63515302-63515303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553362784 | chr8:63515332-63515333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386726139 | chr8:63515347-63515348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572320614 | chr8:63515368-63515369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542529777 | chr8:63515379-63515380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554777562 | chr8:63515381-63515382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576142850 | chr8:63515397-63515398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543546916 | chr8:63515441-63515442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556386629 | chr8:63515447-63515448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1531657 | chr8:63515466-63515467 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs535430012 | chr8:63515486-63515487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555215181 | chr8:63515513-63515514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1531658 | chr8:63515522-63515523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs182128150 | chr8:63515537-63515538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1531659 | chr8:63515609-63515610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72651572 | chr8:63515640-63515641 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs558893234 | chr8:63515641-63515642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1531660 | chr8:63515674-63515675 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs116342609 | chr8:63515702-63515703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1531661 | chr8:63515729-63515730 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs187215410 | chr8:63515735-63515736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552348211 | chr8:63515770-63515771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563149207 | chr8:63515786-63515787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116826051 | chr8:63515822-63515823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149808436 | chr8:63515853-63515854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531654123 | chr8:63515918-63515919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546894986 | chr8:63515982-63515983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371338111 | chr8:63516019-63516020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553722861 | chr8:63516023-63516024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145692424 | chr8:63516066-63516067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34263462 | chr8:63516078-63516079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554673689 | chr8:63516089-63516090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62509499 | chr8:63516096-63516097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74318548 | chr8:63516098-63516099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63515000-63518000 | Enhancers | Fetal Lung | lung |
2 | chr8:63515600-63517000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:63515800-63516000 | Enhancers | Fetal Brain Female | brain |
4 | chr8:63515800-63516400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr8:63516000-63516800 | Enhancers | Fetal Stomach | stomach |
6 | chr8:63516000-63519200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr8:63516200-63516800 | Weak transcription | Fetal Brain Female | brain |
8 | chr8:63516200-63516800 | Enhancers | Fetal Kidney | kidney |
9 | chr8:63516200-63517000 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr8:63516200-63517000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr8:63516200-63517000 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr8:63516200-63517000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr8:63516200-63517000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr8:63516200-63517000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr8:63516200-63517000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr8:63516200-63517000 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
17 | chr8:63516200-63517000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr8:63516200-63517200 | Enhancers | HUES64 Cell Line | embryonic stem cell |